NEW YORK (GenomeWeb) – Great Basin announced today that its Bordetella Direct assay has received CE Marking.
The PCR-based test to detect Bordetella pertussis was granted 510(k) clearance by the US Food and Drug Administration earlier this year and will now be launched commercially.